ArticleJournal of dental sciences2025
Impact of continued antithrombotic use on bleeding risk in oral surgery- a retrospectively study in a population patients treated in a Korean university hospital.
Article in Journal of dental sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Local Hemostasis as the Critical Enabler for Safe Antithrombotic Therapy in Dentistry-Navigating Future Frontiers and Innovative Concepts.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/purpose: With the growing elderly population and their increasing prevalence of systemic diseases, the use of antithrombotic medications is on the rise. These medications are essential for preventing thromboembolic events in patients with cardiovascular, cerebrovascular diseases. However, their use poses challenges in dental surgeries, where the risk of postoperative bleeding needs to be carefully balanced against the risks of discontinuing antithrombotic therapy. This study aimed to assess whether continuing antithrombotic therapy increases the risk of postoperative bleeding during dental procedures. Materials and methods: Retrospective analysis was conducted on 118 patients who underwent oral surgeries, including extractions and dental implants. Patients were categorized based on whether they continued or discontinued antithrombotic therapy before the procedure. Data on age, sex, type of antithrombotic agent, and occurrence of delayed bleeding were collected. Multiple regression analysis was used to identify potential risk factors for postoperative bleeding. Results: Of the 118 patients, 78 continued antithrombotic therapy, while 40 discontinued it. Delayed postoperative bleeding occurred in 10 patients (8.47 %), with no statistically significant difference between those who continued and those who discontinued their medication. The type of antithrombotic agent, interaction between drug cessation and procedure, preoperative platelet count, prothrombin time, and partial thromboplastin time did not significantly affect the incidence of bleeding. Conclusion: Continuing antithrombotic therapy does not significantly increase the risk of postoperative bleeding in patients undergoing oral surgeries. Dental practitioners can consider maintaining antithrombotic therapy during certain procedures, emphasizing the importance of balancing bleeding risks with the potential for thromboembolic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.